Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 12;6(4):e565.
doi: 10.1212/NXI.0000000000000565. eCollection 2019 Jul.

Pilot study of a ketogenic diet in relapsing-remitting MS

Affiliations

Pilot study of a ketogenic diet in relapsing-remitting MS

J Nicholas Brenton et al. Neurol Neuroimmunol Neuroinflamm. .

Abstract

Objective: To assess the safety and tolerability of a modified Atkins diet (KDMAD), a type of ketogenic diet (KD), in subjects with relapsing MS while exploring potential benefits of KDs in MS.

Methods: Twenty subjects with relapsing MS enrolled into a 6-month, single-arm, open-label study of the KDMAD. Adherence to KDMAD was objectively monitored by daily urine ketone testing. Fatigue and depression scores and fasting adipokines were obtained at baseline and on diet. Brain MRI was obtained at baseline and 6 months. Intention to treat was used for primary data analysis, and a per-protocol approach was used for secondary analysis.

Results: No subject experienced worsening disease on diet. Nineteen subjects (95%) adhered to KDMAD for 3 months and 15 (75%) adhered for 6 months. Anthropometric improvements were noted on KDMAD, with reductions in body mass index and total fat mass (p < 0.0001). Fatigue (p = 0.002) and depression scores (p = 0.003) were improved. Serologic leptin was significantly lower at 3 months (p < 0.0001) on diet.

Conclusions: KDMAD is safe, feasible to study, and well tolerated in subjects with relapsing MS. KDMAD improves fatigue and depression while also promoting weight loss and reducing serologic proinflammatory adipokines.

Classification of evidence: The study is rated Class IV because of the absence of a non-KD control group.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Subject-reported outcomes for subjects compliant to KDMAD at 3 (n = 19) and 6 months (n = 15) for depression
(A) Depression scores as a function of time adhering to a modified KD (as assessed by the Beck Depression Inventory) and (B) fatigue levels as a function of time adhering to a modified KD fatigue (as assessed by the Modified Fatigue Impact Scale). Boxplots demonstrate the median and interquartile range. Whiskers represent the range. KD = ketogenic diet.
Figure 2
Figure 2. Change in baseline fasting serologic adipokine levels for compliant subjects at 3 (n = 19) and 6 months (n = 15) on KDMAD
(A) Serologic leptin as function of time adhering to modified KD and (B) serologic adiponectin as a function of time adhering to modified KD. Boxplots demonstrate the median and interquartile range. Whiskers represent the range. KD = ketogenic diet.

References

    1. Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012;18:1334–1336. - PubMed
    1. Brenton JN, Goldman MD. A study of dietary modification: perceptions and attitudes of patients with multiple sclerosis. Mult Scler Relat Disord 2016;8:54–57. - PubMed
    1. Fitzgerald KC, Tyry T, Salter A, et al. . Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology 2018;90:e1–e11. - PubMed
    1. Milder JB, Liang LP, Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis 2010;40:238–244. - PMC - PubMed
    1. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 2004;55:576–580. - PubMed

Publication types